Necrolytic migratory erythema following prolonged continuous subcutaneous dasiglucagon administration: a rare dermatologic adverse event

Clinical management of congenital hyperinsulinism (CHI) remains a significant challenge due to its complex pathophysiology and the limitations of available therapies. Dasiglucagon, a synthetic glucagon analog, represents a novel approach to managing CHI, particularly in patients where conventional t...

Descrición completa

Detalles Bibliográficos

Principais autores:	Lucas Weschle, Jenny Potratz, Frank Rutsch, Alexander Humberg, Sandra Oesingmann, Andreas Pascher, Alexander S Busch, Katja Masjosthusmann
Formato:	Artigo
Idioma:	Inglês
Publicado:	Bioscientifica 2025-04-01
Series:	Endocrinology, Diabetes & Metabolism Case Reports
Assuntos:	necrolytic migratory erythema dasiglucagon congenital hyperinsulinism neonatal hypoglycemia
Acceso en liña:	https://edm.bioscientifica.com/view/journals/edm/2025/2/EDM-25-0006.xml
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!